Please try another search
| Name | Net % | Long % | Short % |
|---|---|---|---|
| Cash | 0.64 | 0.66 | 0.02 |
| Shares | 97.59 | 97.59 | 0.00 |
| Other | 1.78 | 1.78 | 0.00 |
| Ratios | Value | Category Average |
|---|---|---|
| P/E Ratio | 23.04 | 19.29 |
| Price to Book | 4.77 | 4.23 |
| Price to Sales | 6.12 | 2.39 |
| Price to Cash Flow | 16.16 | 15.49 |
| Dividend Yield | 1.07 | 1.12 |
| 5 Years Earnings Growth | 6.16 | 11.01 |
Number of long holdings: 81
Number of short holdings: 1
| Name | ISIN | Weight % | Last | Change % | |
|---|---|---|---|---|---|
| AbbVie | US00287Y1091 | 19.06 | 219.24 | +0.09% | |
| Alnylam | US02043Q1076 | 9.34 | 436.36 | -0.94% | |
| Gilead | US3755581036 | 6.45 | 118.79 | -3.74% | |
| Ascendis Pharma AS | US04351P1012 | 5.42 | 196.86 | -1.21% | |
| argenx ADR | US04016X1019 | 5.05 | 843.83 | -0.84% | |
| Amgen | US0311621009 | 4.09 | 319.35 | +1.19% | |
| Insmed | US4576693075 | 3.13 | 186.99 | +0.71% | |
| Viridian Therapeutics | US92790C1045 | 2.22 | 27.24 | -0.95% | |
| Nuvalent Inc Class A | - | 2.22 | - | - | |
| Cogent Biosciences | US19240Q2012 | 2.13 | 14.780 | +0.41% |
| Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
|---|---|---|---|---|---|---|
| Fidelity 500 Index Institutional Pr | 736.94B | 17.50 | 22.66 | 14.62 | ||
| Fidelity Contrafund | 163.06B | 19.86 | 31.10 | 16.58 | ||
| Fidelity Total Market Index Instl b | 122.54B | 16.87 | 21.85 | 14.04 | ||
| Fidelity Blue Chip Growth | 73.54B | 20.19 | 35.44 | 19.59 | ||
| Fidelity Growth Company | 73.1B | 18.62 | 34.67 | 21.18 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review